Monthly oral ibandronate significantly reduces bone resorption in postmenopausal osteoporosis: 1-year results from MOBILE.

被引：0
|
作者：
Recker, RR
Kendler, DL
Adami, S
Hughes, C
Dumont, E
Schimmer, RC
Cooper, C
机构：
[1] Creighton Univ, Omaha, NE 68178 USA
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[3] Univ Verona, I-37100 Verona, Italy
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] GlaxoSmithKline, Collegeville, PA USA
[6] Univ Southampton, Southampton, Hants, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] Monthly oral ibandronate is at least as effective as oral daily ibandronate in postmenopausal osteoporosis: 1-Year results from MOBILE.
    Miller, PD
    Drezner, HK
    Delmas, PD
    Stakkestad, JA
    Hughes, C
    Bonvoisin, B
    Reginster, JY
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S94 - S94
  • [2] Monthly oral ibandronate is well tolerated in women with postmenopausal osteoporosis: 1-year results from MOBILE.
    Lewiecki, EM
    Miller, PD
    Lorenc, R
    Hughes, C
    Bonvoisin, B
    McClung, MR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S446 - S446
  • [3] Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Miller, PD
    McClung, MR
    Macovei, LV
    Stakkestad, JA
    Luckey, M
    Bonvoisin, B
    Reginster, JY
    Recker, RR
    Hughes, C
    Lewiecki, EM
    Felsenberg, D
    Delmas, PD
    Kendler, DL
    Bolognese, MA
    Mairon, N
    Cooper, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) : 1315 - 1322
  • [4] Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE study
    Recker, RR
    Silverman, SL
    Kendler, DL
    Dumont, E
    Hughes, BBC
    Reginster, JY
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S293 - S294
  • [5] Monthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis: 1-year results from mobile
    Cooper, C
    Stepan, JJ
    Lorenc, R
    Hughes, C
    Mairon, N
    Sedarati, F
    Reginster, JY
    [J]. BONE, 2005, 36 : S417 - S417
  • [6] Favorable safety profile of once-monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from mobile
    Nuti, R
    Stakkestad, JA
    Czerwinski, E
    Leigh, C
    Mairon, N
    Bonvoisin, B
    Cooper, C
    [J]. BONE, 2005, 36 : S418 - S419
  • [7] Monthly oral ibandronate is effective and safe therapy for women with postmenopausal osteoporosis: Mobile 1-year results.
    Epstein, S
    Bolognese, MA
    Miller, P
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S196 - S196
  • [8] Once-monthly oral ibandronate is at least as effective as daily oral ibandronate in postmenopausal osteoporosis: 2-year findings from MOBILE.
    McClung, MR
    Drezner, MK
    Reginster, JY
    Bolognese, M
    Hughes, C
    Mairon, N
    Bonvoisin, B
    Delmas, PD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S395 - S395
  • [9] Large proportions of women with postmenopausal osteoporosis respond to once-monthly oral ibandronate: 2-year results from MOBILE.
    Recker, RR
    Luckey, M
    Stakkestad, JA
    Civitelli, R
    Hughes, C
    Mairon, N
    Bonvoisin, B
    Cooper, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S395 - S395
  • [10] Once monthly dosing increases the proportion of patients who respond to oral ibandronate: 1-year results from MOBILE.
    Emkey, R
    Felsenberg, D
    Stepan, JJ
    Hughes, C
    Dumont, E
    Van der Auwera, P
    Recker, RR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S447 - S447
12345